Hidetoshi Tahara

15PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical virologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 15, 2024
ASO Visual Abstract: Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy.

Ryosuke Hirohata, Yuki Yamamoto, Takahiro Mimae

|Oct 17, 2024
Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy.

Ryosuke Hirohata, Yuki Yamamoto, Takahiro Mimae

|May 25, 2024
Downregulation of Histone H3.3 Induces p53-Dependent Cellular Senescence in Human Diploid Fibroblasts.

Yuki Yamamoto, Ryou-U Takahashi, Masaki Kinehara

|Aug 12, 2023
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis.

Toshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara

|Dec 23, 2022
Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence.

Jiayan Han, Soichiro Hayashi, Ryou-U Takahashi

|Apr 12, 2022
Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways.

Masaki Kato, Haruhiko Ogata, Hidetoshi Tahara

Pageof 3

Frequent Collaborators

6 joint publications

Ryou-U Takahashi

4 joint publications

Yuki Yamamoto

3 joint publications

Yasuhiro Tsutani

2 joint publications

Yosuke Koshikawa